Additionally, DCN promotes the expression of FAS/FASL, induces BMP2k (BMP-2 inducible protein kinase) gene expression, and impacts the tumour microenvironment; through attenuation of TGF-β, DCN stabilizes E-cadherin and other proteins in order to inhibit the development and metastasis of tumour cells [92]. The gene discussed is CDH1; the disease is neoplasm.